WallStreetZenWallStreetZen

NASDAQ: RCM
R1 Rcm Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RCM past earnings growth

How has RCM's earnings growth performed historically?
Company
N/A
Industry
-4.17%
Market
107.08%
RCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

RCM past revenue growth

How has RCM's revenue growth performed historically?
Company
24.79%
Industry
12.11%
Market
17.87%
RCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RCM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RCM earnings and revenue history

Current Revenue
$2.3B
Current Earnings
$3.3M
Current Profit Margin
0.1%
RCM's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RCM Return on Equity

Current Company
0.1%
Current Industry
-0.2%
Current Market
188%
RCM's Return on Equity (0.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RCM announces earnings.

RCM Return on Assets

Current Company
0.1%
Current Industry
0.8%
RCM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RCM Return on Capital Employed

Current Company
3.21%
Current Industry
2.2%
RCM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RCM vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RCM$2.25B$437.70M$3.30M+21.02%-99.16%
DOCS$468.33M$186.53M$137.63M+21.63%-2.02%
TXG$618.73M-$205.11M-$255.10M+33.43%N/A
EVH$1.96B-$24.79M-$142.26M+25.65%N/A
HQY$999.59M$283.57M$55.71M+28.33%-11.54%
View Top Health Information Service Stocks

RCM earnings dates

Next earnings date
May 2, 2024

R1 Rcm Earnings & Revenue FAQ

What were RCM's earnings last quarter?

On Invalid Date, R1 Rcm (NASDAQ: RCM) reported Q4 2023 earnings per share (EPS) of $0.01, up 110% year over year. Total R1 Rcm earnings for the quarter were $1.40 million. In the same quarter last year, R1 Rcm's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy R1 Rcm stock.

What was RCM's earnings growth in the past year?

As of Q2 2024, R1 Rcm's earnings has grown year over year. R1 Rcm's earnings in the past year totalled $3.30 million.

What is RCM's earnings date?

R1 Rcm's earnings date is Invalid Date. Add RCM to your watchlist to be reminded of RCM's next earnings announcement.

What was RCM's revenue last quarter?

On Invalid Date, R1 Rcm (NASDAQ: RCM) reported Q4 2023 revenue of $575.10 million up 7.84% year over year. In the same quarter last year, R1 Rcm's revenue was $533.30 million.

What was RCM's revenue growth in the past year?

As of Q2 2024, R1 Rcm's revenue has grown 24.79% year over year. This is 12.68 percentage points higher than the US Health Information Services industry revenue growth rate of 12.11%. R1 Rcm's revenue in the past year totalled $2.25 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.